ZSCAN4 Expression for Telomere Lengthening Without Tumorigenesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for increasing telomere length in human cells, such as using telomerase or Chinese herb TA-65, are either associated with tumorigenesis or require long-term drug administration, and there is a lack of evidence that Zscan4 expression in human cells would have the same effect as in mouse embryonic stem cells.
Innovation Solution
Increasing expression of Zscan4 in human cells using agents like nucleic acid molecules to induce telomere lengthening and correct genomic and chromosome abnormalities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Length of moving object
If telomerase is used to increase telomere length in human cells, then telomere length is improved, but tumorigenesis risk increases
Solution Approach 1:
The patent uses Zscan4 as an intermediary molecule to achieve telomere lengthening without directly activating telomerase. Zscan4 binds to telomeric DNA and recruits telomerase indirectly, serving as a mediator that decouples the telomere extension function from the uncontrolled proliferation risk associated with direct telomerase activation. This intermediary approach allows selective telomere maintenance in specific cell types while avoiding systemic tumorigenesis.
Solution Approach 2:
The patent changes the regulatory parameters of telomere maintenance by using Zscan4 expression levels rather than direct telomerase activation. By controlling Zscan4 through specific promoters or induction systems, the patent achieves temporal and spatial parameter control over telomere lengthening, preventing constitutive telomerase activity that would lead to cancer while still achieving therapeutic telomere extension when needed.
2Length of moving object
If Chinese herb TA-65 is used to increase telomere length, then telomere length is improved, but long-term drug administration is required
Solution Approach 1:
The patent employs self-service mechanisms where Zscan4 expression triggers self-sustaining telomere lengthening. Once Zscan4 is expressed, it continuously recruits telomerase to maintain and extend telomeres without requiring ongoing external administration. The system becomes self-regulating, with Zscan4 acting as an autonomous agent that maintains telomere length indefinitely after initial expression, eliminating the need for long-term drug therapy.
Solution Approach 2:
The patent implements preliminary action by establishing Zscan4 expression through gene delivery or induction before telomere shortening becomes critical. This upfront establishment of Zscan4 creates a lasting effect that persists through multiple cell divisions, providing long-term telomere maintenance from a single intervention rather than requiring repeated administrations over time.
3Reliability
If Zscan4 expression is increased in human cells, then telomere length and genome stability are improved, but the mechanism is not yet proven in human cells
Solution Approach 1:
The patent incorporates feedback mechanisms to monitor and verify Zscan4 function in human cells. By establishing measurable markers of Zscan4 activity (such as telomere length changes, chromosomal stability indicators, and Zscan4 expression levels), the patent creates a feedback loop that provides empirical evidence of mechanism effectiveness. This systematic monitoring generates the necessary information to confirm Zscan4's role in human cell telomere maintenance and genome stability.
Data Source
AI summary
The present disclosure relates to methods for increasing telomere length in one or more human cells and/or increasing genome stability of one or more human cells, for example by contacting one or more human cells with an agent that increases expression of Zscan4 in the one or more human cells. Methods of treating a subject in need of telomere lengthening, treating a disease or condition associated with a genomic and/or chromosome abnormality, of rejuvenating one or more human cells, of rejuvenating tissues or organs, and of rejuvenating a subject in need thereof, for example by contacting one or more human cells in the subject with an agent that increases expression of Zscan4, or by administering to a subject in need thereof, an agent that increases expression of Zscan4 are also provided.